News Archive

January 15, 2020

Tmunity Announces First Patient Dosed in Phase 1 Clinical Trial with CART-TnMUC1

January 09, 2020

Tmunity to Present at the 38th Annual J.P. Morgan Healthcare Conference

November 06, 2019

Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach

November 04, 2019

Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients

October 31, 2019

Tmunity Raises $75 Million in Series B Financing to Advance Next-Generation T-Cell Therapies

October 01, 2019

Tmunity Announces Exclusive License and Research Collaboration with Children’s Hospital of Philadelphia to Advance GPC2 CAR-T Cell Therapy for Neuroblastoma

September 27, 2019

Tmunity Announces Presentation at the Cantor Fitzgerald 2019 Global Healthcare Conference

August 23, 2019

Tmunity Announces Participation at Upcoming Investor Conferences

July 09, 2019

Be The Match BioTherapies® and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies

May 23, 2019

Tmunity Announces June 2019 Investor Conference Schedule

May 01, 2019

Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers

March 01, 2019

Tmunity Announces Participation at Four Upcoming Investor Conferences

February 14, 2019

Tmunity Appoints Patrick Gray and Garry Nicholson to its Board of Directors as Independent Directors

December 21, 2018

Tmunity to Present at the 37th Annual J.P. Morgan Healthcare Conference

October 02, 2018

FierceBiotech names Tmunity as one of its “Fierce 15” Biotech Companies of 2018

September 18, 2018

Tmunity Names Moji James as General Counsel and Executive Vice President

September 04, 2018

Tmunity Names Graeme Bell as Chief Financial Officer and Executive Vice President

July 10, 2018

Tmunity Appoints Christina Coughlin, MD, PhD, as Chief Medical Officer and Executive Vice President

April 19, 2018

Tmunity Raises Additional $35 Million in Series A Financing, Bringing Series A Total to $135 Million to Advance Next-Generation T Cell Therapies

April 03, 2018

Tmunity Appoints Jason Krentz as Chief Technology Officer and Head of Technical Operations

January 23, 2018

Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer

May 09, 2017

Tmunity Therapeutics Names Michael Christiano Executive Vice President and Chief Business Officer

December 07, 2016

Tmunity Therapeutics Names Usman “Oz” Azam Chief Executive Officer

January 12, 2016

Tmunity Therapeutics, Inc. to Advance IND-Enabling Activities for Personalized Next-Generation Engineered T Cell Therapies with $10 Million Financing

Please reload